Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OROS Hydromorphone vs Morphine SR in Cancer Pain
NCT00803283Phase 3Terminated
- Sponsor
- Johnson & Johnson
- Start
- Nov 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of morphine in cancer pain, sponsored by Johnson & Johnson. Started Nov 2008; status: terminated.
02
Drugs
morphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00803283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00803283.